Phase IIIb, Multicenter, Single-Arm Open-Label Study, Supporting the Development and the Validation of the MATHYS Scale (Multidimensional Assessment of THYmic States) in a Population of Bipolar Patients Treated With Olanzapine, Either in-Label (Manic and Mixed Patients) and Off-Label (Hypomanic and Bipolar Depression)
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2009
At a glance
- Drugs Olanzapine (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 28 Sep 2008 Primary outcome amended as reported by CT.gov
- 17 Jan 2008 Status changed from recruiting to in progress.
- 20 Sep 2006 New trial record.